The DOI matches its Crossref record; 146 of the 147 references it cites were found in a registry or an index.
Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective
Open accessAbstract
The indirect immunofluorescence assay (IIFA) on HEp-2 cells is widely used for detection of antinuclear antibodies (ANA). The dichotomous outcome, negative or positive, is integrated in diagnostic and classification criteria for several systemic autoimmune diseases. However, the HEp-2 IIFA test has much more to offer: besides the titre or fluorescence intensity, it also provides fluorescence pattern(s). The latter include the nucleus and the cytoplasm of interphase cells as well as patterns associated with mitotic cells. The International Consensus on ANA Patterns (ICAP) initiative has previously reached consensus on the nomenclature and definitions of HEp-2 IIFA patterns. In the current paper, the ICAP consensus is presented on the clinical relevance of the 29 distinct HEp-2 IIFA patterns. This clinical relevance is primarily defined within the context of the suspected disease and includes recommendations for follow-up testing. The discussion includes how this information may benefit the clinicians in daily practice and how the knowledge can be used to further improve diagnostic and classification criteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, screening for antinuclear antibodies (ANA) is one of the mandatory steps in the diagnosis of SLE or any other non-specific autoimmune disease [15]”
From Anti-double stranded DNA antibodies: A rational diagnostic approach in limited-resource settings (2022) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“some ANA IIFA patterns may have a good orientation value towards certain specificities, including anti-dsDNA Abs, and therefore should order specific tests accordingly [15].”
From Anti-double stranded DNA antibodies: A rational diagnostic approach in limited-resource settings (2022) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Petri, M., Orbai, A., Alarcón, G. S., Gordon, C., Merrill, J. T., Fortin, P. R., Bruce, I. N., Isenberg, D., Wallace, D. J., Nived, O., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34473 · Cited by 5,322
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S., Prosek, J., Nadasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,376
(2016) · Diagnostic Imaging: Brain · doi:10.1016/b978-0-323-37754-6.50094-4 · Cited by 3,990
van den Hoogen, F., Khanna, D., Fransen, J., Johnson, S. R., Baron, M., Tyndall, A., Matucci-Cerinic, M., Naden, R. P., Medsger, T. A., Carreira, P. E., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204424 · Cited by 2,886
Sharp, G. C., Irvin, W. S., Tan, E. M., Gould, R. G., & Holman, H. R. (1972) · The American Journal of Medicine · doi:10.1016/0002-9343(72)90064-2 · Cited by 1,835
Lundberg, I. E., Tjärnlund, A., Bottai, M., Werth, V. P., Pilkington, C., Visser, M. D., Alfredsson, L., Amato, A. A., Barohn, R. J., Liang, M. H., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211468 · Cited by 1,557
Hirschfield, G. M., Beuers, U., Corpechot, C., Invernizzi, P., Jones, D., Marzioni, M., & Schramm, C. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.022 · Cited by 1,480
Shiboski, C. H., Shiboski, S. C., Seror, R., Criswell, L. A., Labetoulle, M., Lietman, T. M., Rasmussen, A., Scofield, H., Vitali, C., Bowman, S. J., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210571 · Cited by 1,414
EASL Clinical Practice Guidelines: autoimmune hepatitis
(2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.06.030 · Cited by 1,245
Myositis‐specific autoantibodies: an important tool to support diagnosis of myositis
Betteridge, Z., & McHugh, N. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12451 · Cited by 1,056
Cited by
Mammen, A. L., Allenbach, Y., Stenzel, W., Benvéniste, O., Allenbach, Y., Benvéniste, O., Bleecker, J. D., Boyer, O., Casciola-Rosen, L. A., Christopher‐Stine, L., et al. (2019) · Neuromuscular Disorders · doi:10.1016/j.nmd.2019.10.005 · Cited by 357
Self-citationNew insights into the role of antinuclear antibodies in systemic lupus erythematosus
Pisetsky, D. S., & Lipsky, P. E. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0480-7 · Cited by 303
Systemic Lupus Erythematosus: New Diagnostic and Therapeutic Approaches
Lazar, S., & Kahlenberg, J. M. (2023) · Annual Review of Medicine · doi:10.1146/annurev-med-043021-032611 · Cited by 233
Clinical and Immunological Biomarkers for Systemic Lupus Erythematosus
Yu, H., Nagafuchi, Y., & Fujio, K. (2021) · Biomolecules · doi:10.3390/biom11070928 · Cited by 205
“Although the IIF assay on HEp-2 cells is widely used for detecting ANA [25], enzymelinked immunosorbent assay (ELISA) has also been used [29].”
BackgroundMethodRetracted: Increasing Prevalence of Antinuclear Antibodies in the United States
Dinse, G. E., Parks, C. G., Weinberg, C. R., Co, C. A., Wilkerson, J., Zeldin, D. C., Chan, E. K. L., & Miller, F. W. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41214 · Cited by 192
“The standard HEp2 assay for ANA detects a heterogeneous group of autoantibodies and is a commonly used diagnostic tool in a clinical context (15).”
BackgroundMethodSelf-citationRetracted
Metadata
- Authors
- Damoiseaux, J., Andrade, L. E. C., Carballo, O. G., Conrad, K., Francescantonio, P. L. C., Fritzler, M. J., Garcia de la Torre, I., Herold, M., Klotz, W., Cruvinel, W. D. M., Mimori, T., von Muhlen, C., Satoh, M., & Chan, E. K.
- Affiliations
- Maastricht University Medical Centre (NL)
- Hospital Italiano de Buenos Aires (AR)
- Technische Universität Dresden (DE)
- Innsbruck Medical University (AT)
- Pontifícia Universidade Católica de Goiás (BR)
- Kyoto University (JP)
- University of Occupational and Environmental Health Japan (JP)
- University of Florida (US)
- Corresponding author
- Damoiseaux, Jan
- ORCID
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 78
- Issue
- 7
- Pages
- 879-889
- ISSN
- 0003-4967 (ISSN-L)
- PMC
- PMC6585284
- OpenAlex
- W2921652873
- Cited by
- 378
- References
- 147
- Citations by year
- 2026: 54 · 2025: 50 · 2024: 53 · 2023: 46 · 2022: 56 · 2021: 58 · 2020: 40 · 2019: 20
- FWCI
- 32.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc/4.0/ (vor)
- Locations
- Annals of the Rheumatic Diseases (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, cc-by-nc)
- HighWire Press Open Archive (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Funders
- Japan Society for the Promotion of Science (19K08617)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Keywords
- antinuclear antibodies, HEp-2 cells, systemic autoimmune diseases, diagnostic criteria, classification criteria, follow-up testing, mitotic cells
- MeSH terms
- Antibodies, Antinuclear, Autoimmune Diseases, Humans, International Cooperation, Biomarkers, Fluorescent Antibody Technique, Indirect
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective. https://app.cochat.ai/papers/10.1136/annrheumdis-2018-214436
- The paper
- Damoiseaux, J., Andrade, L. E. C., Carballo, O. G., Conrad, K., Francescantonio, P. L. C., Fritzler, M. J., Garcia de la Torre, I., Herold, M., Klotz, W., Cruvinel, W. D. M., Mimori, T., von Muhlen, C., Satoh, M., & Chan, E. K. (2019). Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2018-214436
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.